Aptus Pharma Limited
Quick Take
- • Trading at 113.6× trailing earnings
- • Strong ROE at 30.5%
- • Low leverage (D/E 0.31)
- • No dividend data
- • Operating margin 13.2% · Net margin 9.9%
- • Profit growth +111.20% YoY · Beta —
Latest quarter · Mar 2026
| ₹ Cr | Mar 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 32 | +113.33% | — |
| Operating Profit | 5 | +66.67% | — |
| Net Profit | 3 | +50.00% | — |
| EPS (₹) | 1.68 | +60.00% | — |
Shareholding Pattern
About the company
From latest AR & concallAptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division, which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division, which includes marketing of chronic therapies, including antihypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. In additio, the company develops and markets skin care, face care, hair care, personal hygiene, wellness, and self-care over-the-counter products. Its products are available in balms, capsules, drops, gels, injections, lotions, ointments, powders, sachets, softgels, solutions, suspensions, syrups, tablets, and vials. It distributes the products through clearing and forwarding agents. Aptus Pharma Limited was incorporated in 2010 and is headquartered in Rajkot, India.
